A carregar...

Continuation treatment of major depressive disorder: is there a case for duloxetine?

Duloxetine is a serotonin–noradrenaline reuptake inhibitor with established efficacy for the short-term treatment of major depressive disorder. Efficacy in continuation treatment (greater than six months of continuous treatment) has been established from both open and placebo-controlled relapse prev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Norman, Trevor R, Olver, James S
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2846146/
https://ncbi.nlm.nih.gov/pubmed/20368904
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!